drugset / Trial / NCT00962182

Study of Enzyme Supplements to Treat Celiac Disease

NCT00962182 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to examine whether a cocktail of two common food-grade enzyme supplements leads to decrease of serum activity markers in celiac disease patients insufficiently treated by previous gluten exclusion.

Timeline

Start
2008-08
Primary completion
2014-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject STAN1 Unknown — —